Insiders · Profile

Mullennix Stephen

Chief Operating Officer at UroGen Pharma. Filing since 14 Feb 2019. CIK 0001764139

Company
Date
Role
Action
Shares
Amount
Of holding
27 Apr 2020
Chief Operating Officer
Sold, plan not stated
145
$3.53K
1.4%
14 Feb 2020
Chief Operating Officer
Sold, plan not stated
612
$17.16K
5.9%
27 Jan 2020
Chief Operating Officer
Sold, plan not stated
684
$20.01K
7.3%
14 Nov 2019
Chief Operating Officer
Sold, plan not stated
608
$15.81K
7.3%
15 Aug 2019
Chief Operating Officer
Sold, plan not stated
608
$19.24K
8.5%
14 May 2019
Chief Operating Officer
Sold, plan not stated
608
$23.09K
10.2%
14 Feb 2019
Chief Operating Officer
Sold, plan not stated
2,804
$104.59K
39.9%
7 decisions on file.